Predicting immunotherapy response with spatial data

Recent studies demonstrate that spatial proximity metrics of immune and tumor cells significantly outperform traditional PD-L1 expression testing in predicting immunotherapy response across multiple cancer types, suggesting multi-marker spatial models provide improved predictive power for clinical use.

This Wire brief sits within Fusion42's coverage of Drug Discovery. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.